The trial posting for A phase 1 randomized, double-blind, placebo-controlled, two-way crossover study to assess the effect of PF-05175157 as a single oral dose on metabolic and cardiopulmonary parameters during steady state and graded exercise in healthy subjects is not listed as active in database. The trial may have stopped recruiting.